Business Description
Gongwin Biopharm Holdings Co Ltd
ISIN : KYG409471060
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -1.74 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 60.16 | |||||
Beneish M-Score | 14.4 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 175.3 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 2.7 | |||||
3-Year FCF Growth Rate | 4.1 | |||||
3-Year Book Growth Rate | 5.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.29 | |||||
9-Day RSI | 41.14 | |||||
14-Day RSI | 42.39 | |||||
6-1 Month Momentum % | 6.03 | |||||
12-1 Month Momentum % | -40.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.86 | |||||
Quick Ratio | 8.76 | |||||
Cash Ratio | 8.55 | |||||
Days Inventory | 778.23 | |||||
Days Sales Outstanding | 131.63 | |||||
Days Payable | 419.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 0.19 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.58 | |||||
Operating Margin % | -384.48 | |||||
Net Margin % | -280.89 | |||||
FCF Margin % | -624.9 | |||||
ROE % | -3.65 | |||||
ROA % | -3.14 | |||||
ROIC % | -14.94 | |||||
ROC (Joel Greenblatt) % | -23.83 | |||||
ROCE % | -3.57 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1159.24 | |||||
PB Ratio | 15.68 | |||||
Price-to-Tangible-Book | 15.68 | |||||
EV-to-EBIT | -384.96 | |||||
EV-to-EBITDA | -441.91 | |||||
EV-to-Revenue | 1104.57 | |||||
EV-to-FCF | -177.27 | |||||
Price-to-Net-Current-Asset-Value | 22.44 | |||||
Price-to-Net-Cash | 23.42 | |||||
Earnings Yield (Greenblatt) % | -0.26 | |||||
FCF Yield % | -0.54 |